SYNOPHYLATE Drug Patent Profile
✉ Email this page to a colleague
When do Synophylate patents expire, and when can generic versions of Synophylate launch?
Synophylate is a drug marketed by Cent Pharms and is included in one NDA.
The generic ingredient in SYNOPHYLATE is theophylline sodium glycinate. There are thirty-six drug master file entries for this compound. Additional details are available on the theophylline sodium glycinate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SYNOPHYLATE?
- What are the global sales for SYNOPHYLATE?
- What is Average Wholesale Price for SYNOPHYLATE?
Summary for SYNOPHYLATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 24 |
| Patent Applications: | 108 |
| DailyMed Link: | SYNOPHYLATE at DailyMed |
US Patents and Regulatory Information for SYNOPHYLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cent Pharms | SYNOPHYLATE | theophylline sodium glycinate | ELIXIR;ORAL | 006333-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
